Tandem AI Prescription Startup Reaches $1 Billion Valuation, Revolutionizing Medication Access…
Tandem AI prescription startup just achieved a remarkable $1 billion valuation, cementing its position among health tech unicorns 2026 and marking a watershed moment for AI in pharmacy innovation. This New York-based company has quietly…
Read More...
Read More...
